𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The molecular basis of porphyria cutanea tarda in Chile: Identification and functional characterization of mutations in the uroporphyrinogen decarboxylase gene

✍ Scribed by Pamela Poblete-Gutiérrez; Manuel Mendez; Tonio Wiederholt; Hans F. Merk; Antonio Fontanellas; Carlos Wolff; Jorge Frank


Book ID
110754960
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
677 KB
Volume
13
Category
Article
ISSN
0906-6705

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Three new mutations in the uroporphyrino
✍ Julie F. McManus; C. Glenn Begley; S. Sassa; Sujiva Ratnaike 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 28 KB 👁 2 views

We have characterised three new mutations in the uroporphyrinogen decarboxylase gene in familial porphyria cutanea tarda. The first of these was a G to A substitution in the 5' splice junction of exon 4 which generated an mRNA that lacked exon 4. The second was a nonsense mutation in exon 5 which ch

Seven novel point mutations in the uropo
✍ M.D. Cappellini; F. Martinez di Montemuros; D. Tavazzi; S. Fargion; A. Pizzuti; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

In this work, we describe seven novel molecular defects in the uroporphyrinogen decarboxylase gene responsible for familial porphyria cutanea tarda in Italian subjects with reduced erythrocyte URO-D activity. Four of these molecular abnormalities (R142Q, L161Q, S219F, P235S) are missense mutations,

Hepatic uroporphyrinogen decarboxylase a
✍ Maria Jose Moran; Antonio Fontanellas; Eric Brudieux; Isabelle Hombrados; Victor 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Porphyria cutanea tarda (PCT) is caused by a decreased activity of the hepatic enzyme uroporphyrinogen decarboxylase (URO-D). This deficiency causes overproduction, hepatic deposition, and increased excretion of uroporphyrin. Iron overload and hepatic viral infections are considered aggravating fact

Molecular basis of congenital erythropoi
✍ Weiming Xu; Kenneth H. Astrin; Robert J. Desnick 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

Congenital erythropoietic porphyria (CEP) is an autosomal recessive inborn error of metabolism that results from the markedly deficient activity of the fourth enzyme in the heme biosynthetic pathway, uroporphyrinogen 111 synthase (URO-synthase). T o date, 17 mutations have been described including 1